ES532905A0 - Un procedimiento para preparar un ester de acido carboxilico de un esteroide - Google Patents
Un procedimiento para preparar un ester de acido carboxilico de un esteroideInfo
- Publication number
- ES532905A0 ES532905A0 ES532905A ES532905A ES532905A0 ES 532905 A0 ES532905 A0 ES 532905A0 ES 532905 A ES532905 A ES 532905A ES 532905 A ES532905 A ES 532905A ES 532905 A0 ES532905 A0 ES 532905A0
- Authority
- ES
- Spain
- Prior art keywords
- steroid
- preparing
- procedure
- acid ester
- carboxyl acid
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- -1 CARBOXYL Chemical class 0.000 title abstract 2
- 239000002253 acid Substances 0.000 title 1
- 150000002148 esters Chemical class 0.000 title 1
- 150000003431 steroids Chemical class 0.000 title 1
- 239000003377 acid catalyst Substances 0.000 abstract 1
- 230000015572 biosynthetic process Effects 0.000 abstract 1
- 150000001718 carbodiimides Chemical class 0.000 abstract 1
- 230000003197 catalytic effect Effects 0.000 abstract 1
- 239000003795 chemical substances by application Substances 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 238000003786 synthesis reaction Methods 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J9/00—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of more than two carbon atoms, e.g. cholane, cholestane, coprostane
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
- C07J1/0003—Androstane derivatives
- C07J1/0011—Androstane derivatives substituted in position 17 by a keto group
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
- C07J1/0051—Estrane derivatives
- C07J1/0059—Estrane derivatives substituted in position 17 by a keto group
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
- C07J1/0051—Estrane derivatives
- C07J1/0066—Estrane derivatives substituted in position 17 beta not substituted in position 17 alfa
- C07J1/007—Estrane derivatives substituted in position 17 beta not substituted in position 17 alfa the substituent being an OH group free esterified or etherified
- C07J1/0074—Esters
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
- C07J41/0033—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005
- C07J41/005—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005 the 17-beta position being substituted by an uninterrupted chain of only two carbon atoms, e.g. pregnane derivatives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J5/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond
- C07J5/0046—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa
- C07J5/0053—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa not substituted in position 16
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Steroid Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Ultra Sonic Daignosis Equipment (AREA)
- Investigating Or Analyzing Materials By The Use Of Ultrasonic Waves (AREA)
- Amplifiers (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| SE8303031A SE8303031D0 (sv) | 1983-05-30 | 1983-05-30 | Improved steroid esters preparation |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| ES8503008A1 ES8503008A1 (es) | 1985-02-01 |
| ES532905A0 true ES532905A0 (es) | 1985-02-01 |
Family
ID=20351375
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ES532905A Granted ES532905A0 (es) | 1983-05-30 | 1984-05-29 | Un procedimiento para preparar un ester de acido carboxilico de un esteroide |
Country Status (18)
| Country | Link |
|---|---|
| US (1) | US4537722A (es) |
| EP (1) | EP0127829B1 (es) |
| JP (1) | JPS6041696A (es) |
| AT (1) | ATE32603T1 (es) |
| AU (1) | AU560235B2 (es) |
| CA (1) | CA1211430A (es) |
| DE (1) | DE3469440D1 (es) |
| DK (1) | DK162100C (es) |
| ES (1) | ES532905A0 (es) |
| FI (1) | FI80710C (es) |
| GR (1) | GR82048B (es) |
| HU (1) | HU198217B (es) |
| IE (1) | IE57425B1 (es) |
| IL (1) | IL71870A (es) |
| NZ (1) | NZ208174A (es) |
| PT (1) | PT78661B (es) |
| SE (1) | SE8303031D0 (es) |
| ZA (1) | ZA843946B (es) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES2261836T3 (es) * | 1993-01-19 | 2006-11-16 | Endorecherche Inc. | Usos terapeuticos de dehidroepiandrosterona para tratamiento de libido disminuida y osteoporosis. |
| US5776923A (en) * | 1993-01-19 | 1998-07-07 | Endorecherche, Inc. | Method of treating or preventing osteoporosis by adminstering dehydropiandrosterone |
| DE4433374A1 (de) * | 1994-09-20 | 1996-03-21 | Hoechst Ag | 17-Desoxi-corticosteroid-21-/O/-Carbonsäure- ester, Verfahren zu deren Herstellung und diese enthaltende Arzneimittel |
| US5892068A (en) * | 1998-08-25 | 1999-04-06 | Mcneil-Ppc, Inc. | Preparation of sterol and stanol-esters |
| US6087522A (en) * | 1999-10-12 | 2000-07-11 | Fan Tech Corporation | Silicone lanolin esters |
| WO2005070951A1 (en) | 2004-01-16 | 2005-08-04 | Cedarburg Pharmaceuticals, Inc. | Exemestane and its intermediates and methods of making the same |
| ES2459920T3 (es) * | 2008-11-10 | 2014-05-12 | Bridgestone Corporation | Caucho natural modificado y método para la producción de caucho natural modificado y composición de caucho y neumático utilizando ésta |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB1050883A (es) * | ||||
| DE1958954C3 (de) * | 1969-11-24 | 1978-11-30 | Schering Ag, 1000 Berlin Und 4619 Bergkamen | Verfahren zur Veresterung von Alkoholen |
| US3678082A (en) * | 1970-07-30 | 1972-07-18 | Searle & Co | Esterification of 17-hydroxy steroids |
| GB1558472A (en) * | 1976-01-22 | 1980-01-03 | Leo Ab | 17-esters of 17- hydroxy gestogens |
| GB1565680A (en) * | 1976-12-31 | 1980-04-23 | Leo Ab | Method for the preparation of carboxylic acid esters |
-
1983
- 1983-05-30 SE SE8303031A patent/SE8303031D0/xx unknown
-
1984
- 1984-05-14 IE IE1192/84A patent/IE57425B1/en not_active IP Right Cessation
- 1984-05-16 NZ NZ208174A patent/NZ208174A/en unknown
- 1984-05-18 IL IL71870A patent/IL71870A/xx not_active IP Right Cessation
- 1984-05-18 CA CA000454726A patent/CA1211430A/en not_active Expired
- 1984-05-19 DE DE8484105741T patent/DE3469440D1/de not_active Expired
- 1984-05-19 EP EP84105741A patent/EP0127829B1/en not_active Expired
- 1984-05-19 AT AT84105741T patent/ATE32603T1/de not_active IP Right Cessation
- 1984-05-24 ZA ZA843946A patent/ZA843946B/xx unknown
- 1984-05-28 GR GR74846A patent/GR82048B/el unknown
- 1984-05-29 DK DK265484A patent/DK162100C/da not_active IP Right Cessation
- 1984-05-29 PT PT78661A patent/PT78661B/pt unknown
- 1984-05-29 US US06/614,991 patent/US4537722A/en not_active Expired - Lifetime
- 1984-05-29 ES ES532905A patent/ES532905A0/es active Granted
- 1984-05-29 HU HU842072A patent/HU198217B/hu unknown
- 1984-05-30 JP JP59110667A patent/JPS6041696A/ja active Granted
- 1984-05-30 AU AU28832/84A patent/AU560235B2/en not_active Expired
- 1984-05-30 FI FI842164A patent/FI80710C/fi not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| EP0127829A3 (en) | 1985-08-07 |
| FI80710C (fi) | 1990-07-10 |
| IE57425B1 (en) | 1992-09-09 |
| DE3469440D1 (en) | 1988-03-31 |
| ES8503008A1 (es) | 1985-02-01 |
| CA1211430A (en) | 1986-09-16 |
| ATE32603T1 (de) | 1988-03-15 |
| DK265484A (da) | 1984-12-01 |
| EP0127829B1 (en) | 1988-02-24 |
| JPS6041696A (ja) | 1985-03-05 |
| GR82048B (es) | 1984-12-12 |
| JPH0369360B2 (es) | 1991-10-31 |
| AU2883284A (en) | 1984-12-06 |
| FI80710B (fi) | 1990-03-30 |
| ZA843946B (en) | 1984-12-24 |
| IL71870A0 (en) | 1984-09-30 |
| NZ208174A (en) | 1987-04-30 |
| DK162100C (da) | 1992-02-24 |
| SE8303031D0 (sv) | 1983-05-30 |
| DK162100B (da) | 1991-09-16 |
| DK265484D0 (da) | 1984-05-29 |
| IL71870A (en) | 1986-10-31 |
| EP0127829A2 (en) | 1984-12-12 |
| FI842164A0 (fi) | 1984-05-30 |
| FI842164L (fi) | 1984-12-01 |
| IE841192L (en) | 1984-11-30 |
| PT78661B (en) | 1986-06-26 |
| PT78661A (en) | 1984-06-01 |
| HU198217B (en) | 1989-08-28 |
| US4537722A (en) | 1985-08-27 |
| AU560235B2 (en) | 1987-04-02 |
| HUT34222A (en) | 1985-02-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE54154T1 (de) | Retro-inverse analoga des bradykininpotentialisierenden peptids bpp-5a und verfahren zu ihrer herstellung. | |
| ATE58534T1 (de) | 2-pyrimidinyl-l-piperazin-derivate, verfahren zu ihrer herstellung und diese enthaltende arzneimittel. | |
| DE69432109D1 (de) | Synthetische, vielfache tandemwiederholungen des mucinpeptides und seiner derivate und deren verwendung | |
| TR200001079T2 (tr) | Bisiklik kinaz inhibitörleri. | |
| ES2155872T3 (es) | Triestannoxanos. | |
| ES532905A0 (es) | Un procedimiento para preparar un ester de acido carboxilico de un esteroide | |
| ES8609232A1 (es) | Procedimiento para la preparacion de un analogo a la prosta-glandina | |
| ATE191467T1 (de) | Herstellung von amidoester-verbindungen | |
| DE3578687D1 (de) | N-substituierte neuraminsaeure-derivate und verfahren zu ihrer herstellung. | |
| TR200101083T2 (tr) | (7alfa,17alfa)-17-hidroksi- 7-metil-19-nor-17-pregn-5 (10)-en-20-in-3-on içeren yüksek saflıkta bileşim. | |
| IE46290L (en) | Improved method of preparing carboxylic acid esters | |
| ES8401448A1 (es) | Procedimiento para la preparacion de insulinas a partir de compuestos analogos a preproinsulina. | |
| ATE256664T1 (de) | Herstellung von (s)-decahydroisochinolin-3- carbonsäure-t-butylamid | |
| IT1064999B (it) | Procedimento per la preparazione di acido tereftalico purificato | |
| ATE207936T1 (de) | Verfahren zur herstellung von celluloseacetat | |
| ES2131707T3 (es) | Procedimiento para la obtencion de un compuesto diolico. | |
| PT83837A (de) | Verfahren zur herstellung von peptiden unter der verwendung von perchloraten | |
| ATE135356T1 (de) | Salicylaldehyd- und salicylsäurederivate sowie deren schwefelanaloge, verfahren und zwischenprodukte zu ihrer herstellung | |
| ES8505351A1 (es) | Un procedimiento para preparar nuevas aroilimidazolonas | |
| ES8600768A1 (es) | Imidazotiadiazolalquencarboxiamidas | |
| JPS5320435A (en) | Remedies for hypertension | |
| JPS51128909A (en) | Process for preparing polyglycolic acid salts | |
| JPS51113809A (en) | Process for preparation of 1,3-propanediols | |
| JPS57192350A (en) | Human parathyroid hormone peptide fragment (1-44) | |
| KR880000090B1 (en) | Process for the preparation of n-cinnamoyl-anthranilic acids |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PC1A | Transfer granted | ||
| PC1A | Transfer granted |